Sex differences in glycine biosynthesis drives sex-specific responses to combined nutrient deprivation and pharmacological inhibition in brain tumors

Clicks: 16
ID: 329408
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #101 of 144 articles by views in Neuro-Oncology Advances

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 144 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Glioblastoma (GBM) is the deadliest brain tumor. Generally, male GBM occur at higher incidence and demonstrate shorter overall survival compared to females. Targetable drivers of this phenomenon remain undisclosed, preventing the integration of sex differences into the design of targeted therapeutics. Methods Here, we utilized metabolite tracing, pharmacological blockade, and nutrient deprivation to profile and target putative sex differences in cellular proliferation driven by the synthesis of glycine and nucleotides from glucose. Results Utilizing an established murine model of GBM (Nf1-/-DNp53), we observed male biases in de novo glycine biosynthesis and in the cellular response to inhibition of this pathway in nutrient-replete media. Additionally, we illustrated that removal of exogenous glycine or nucleotide salvage metabolites enhanced inhibition efficacy in both male and female tumor cells. Collectively, our paradigm targets sex differences in the endogenous synthesis of glycine, which coordinates with cellular uptake of exogenous glycine or nucleotide salvage metabolites, to stall nucleotide biosynthesis and cellular proliferation. Findings These data suggest inhibition of de novo glycine biosynthesis may elicit a sex-biased therapeutic response in GBM. Additionally, this work opens the doors to future studies involving dietary restriction of glycine in combination with pharmacological inhibition of de novo glycine biosynthesis as a means to improve outcomes in patients with brain tumors.
Reference Key
openalex_W7214013781 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Camryn Marquez, Jianyun Lu, Kevin Cho, Shanshan Zhang, Jingqin Luo, Joshua B. Rubin, Gary J. Patti, Joseph E. Ippolito
Are you one of these authors? Claim your profile
Journal Neuro-Oncology Advances
Year 2026
DOI
10.1093/noajnl/vdag245
URL
https://doi.org/10.1093/noajnl/vdag245
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.